Evidence map›Paper›PMID 29950509›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

Foxo3 Promotes Apoptosis of B Cell Receptor-Stimulated Immature B Cells, Thus Limiting the Window for Receptor Editing.

Kristina Ottens, Rochelle M Hinman, Evan Barrios, Brian Skaug, Laurie S Davis, Quan-Zhen Li, Diego H Castrillon, Anne B Satterthwaite

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. RNA Methylation in Systemic Lupus Erythematosus.Frontiers in cell and developmental biology · 2021
    Review
  9. Proliferation and Apoptosis of B-Cell Lymphoma Cells under Targeted Regulation of FOXO3 by miR-155.Mediterranean journal of hematology and infectious diseases · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kristina OttensRheumatic Diseases Division, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390.
Rochelle M HinmanRheumatic Diseases Division, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390.
Evan BarriosRheumatic Diseases Division, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0003-2379-1004
Brian SkaugRheumatic Diseases Division, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390.
Laurie S DavisRheumatic Diseases Division, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390.
Quan-Zhen LiDepartment of Immunology, The University of Texas Southwestern Medical Center, Dallas, TX 75390.ORCID 0000-0002-7257-0489
Diego H CastrillonDepartment of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX 75390; and.
Anne B SatterthwaiteRheumatic Diseases Division, Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390; anne.satterthwaite@utsouthwestern.edu.
The University of Texas Southwestern Medical Center · US

Funding

INTEGRATIVE IMMUNOLOGY TRAINING PROGRAMT32AI005284 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Nan Yan · 2003 to 2026
$7.4M
Regulation of B Cell Gene Expression Patterns by BtkR01AI049248 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI SATTERTHWAITE, ANNE B · 2003 to 2007
$1.5M
Attenuation of Lupus by Foxo3R21AR067625 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI SATTERTHWAITE, ANNE B · 2015 to 2016
$391k
NIAID NIH HHS R01 AI049248NIAID NIH HHS T32 AI005284NIAMS NIH HHS R21 AR067625
6 · The paper itself

Abstract

Central tolerance checkpoints are critical for the elimination of autoreactive B cells and the prevention of autoimmunity. When autoreactive B cells encounter their Ag at the immature B cell stage, BCR cross-linking induces receptor editing, followed by apoptosis if edited cells remain autoreactive. Although the transcription factor Foxo1 is known to promote receptor editing, the role of the related factor Foxo3 in central B cell tolerance is poorly understood. We find that BCR-stimulated immature B cells from Foxo3-deficient mice demonstrate reduced apoptosis compared with wild type cells. Despite this, Foxo3

Indexed as

AnimalsApoptosisAutoantibodiesAutoantigensAutoimmunityB-LymphocytesCell DifferentiationFemaleForkhead Box Protein O3Immune ToleranceLupus Erythematosus, SystemicMiceMice, Inbred C57BLMice, TransgenicPrecursor Cells, B-LymphoidReceptors, Antigen, B-CellAutoantibodiesAutoantigensForkhead Box Protein O3FoxO3 protein, mouseReceptors, Antigen, B-Cell

Identifiers

PMID29950509
PMCPMC6057821
OpenAlexW2810066289

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.